Dr. Tae Kon Kim is interested in dissecting mechanisms of immune evasion and developing new therapeutic modalities for the treatment of leukemia. He has received research training under the mentorship of Dr. Lieping Chen, a pioneer in the field of immuno-oncology responsible for key discoveries involving PD-L1 and its interaction with PD-1 in cancer patients. Dr. Kim's translational investigations have focused on the role of novel co-inhibitory molecules during immune evasion in leukemia. He is also interested in selectively inhibiting graft-versus-host disease with sparing graft-versus-leukemia by manipulating co-stimulatory and co-inhibitory molecules. When he's not exploring new ways to treat cancer, Dr. Kim enjoys playing golf, tennis, and skiing. His achievements include receiving the American Society of Hematology Scholar Award, American Society of Clinical Oncology Career Development Award, the EvansMDS Young Investigator Award, and the American Cancer Society Clinician Scientist Development Grant.
Tae Kon Kim, MD, PhD
Assistant Professor of Medicine
Seoul, South Korea
PhD, Immunology/Biomedical Sciences - University of Texas, 2010
MD - Seoul National University College of Medicine, 2001